The Difference Between Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma

Lymphomas are classified based on the type of cells involved. Non-Hodgkin’s lymphomas are marked by mutations of B-cells or T-cells. Hodgkin’s lymphoma is marked by the presence of special type of cell called a Reed-Sternberg cell.

But there are many other differences between Non-Hodgkin’s and Hodgkin’s lymphomas; they involve, among other things, the treatment options, survival rate, incidence, and symptoms.

Age

Hodgkin’s Lymphoma typically occurs in younger patients, age 15 to 24, and older patients over 60.

Non-Hodgkin’s Lymphoma is rare in young patients. Most diagnoses are made in patients over 60 years old.

Incidence

Hodgkin’s Lymphoma accounts for less than 1% of all cancers diagnosed in the U.S. per year. This represents about 15% of all lymphomas.

Non-Hodgkin’s Lymphoma accounts for about 4% of all cancers diagnosed in the U.S. per year. This represents around 85% of all lymphomas.

For both types of lymphomas, more men are affected than women.

Location

Hodgkin’s Lymphoma usually starts in the lymph nodes in the neck. However, it can spread to other lymph node groups, the lungs, spleen, and bone marrow, depending on the stage.

Non-Hodgkin’s Lymphoma can start in a variety of locations depending on the type of cancer and cells affected.

Symptoms

Hodgkin’s Lymphoma often presents with fever and night sweats, which are Grade B symptoms.

Non-Hodgkin’s Lymphoma is less likely to present with Grade B symptoms.

Progression

Hodgkin’s Lymphoma progresses in an orderly fashion between lymph groups, and is often caught before Stage IV.

Non-Hodgkin’s Lymphomas are less orderly, sometimes more aggressive, and are more likely to be caught in advanced stages.

Outcome

Hodgkin’s Lymphoma is considered one of the most treatable cancers. With the discovery of new chemotherapy and radiation protocols, survival in the early years is over 90%.

Non-Hodgkin’s Lymphoma has a lower survival rate in most cases, though it varies by type. Some diseases have survival rates over 80%, though some of the more aggressive and rare types have lower rates.

Related Articles

Photo: Pexels

More Articles

More Articles

According to a study by Japanese researchers, the SMILE combination chemotherapy protocol is effective against extranodal natural killer/T-cell...

Patients treated with maintenance rituximab had three times longer progression-free survival. This is a summary of an article published in the...

When you consider that the adult human body has anywhere from 300 to 700 lymph nodes, the better question might not be where ARE they located, but...

This entry looks at a non-Hodgkin's lymphoma called true histiocytic lymphoma (THL), also referred to as diffuse histiocytic lymphoma, and...

Lymphomatous meningitis [LM], also known as leukemic meningitis, is an extremely serious peripheral cancer that attacks the tissue that covers the...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Intravascular lymphoma is a subtype of 'Lymphoma', an umbrella term that loosely refers to several dozen...

While the average lifespan for hamsters is only about 2.5 years, and they are therefore less prone to long-term illnesses, it is possible for a...

Burkitt's lymphoma is an aggressive B-cell lymphoma that is common in children...

Lymphoma is a cancer of the lymphatic system, causing B-cell or...

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...

Lymphoma is a life-threatening disease, but is very treatable in most cases. The 5-year survival for patients diagnosed with non-Hodgkin's...

T cell lymphoma treatment options for these cancers are not especially effective and there is no absolute consensus about optimal treatments for...

Marginal zone lymphomas (MZL) are indolent lymphomas that affect the B-cells. The...

Lymphomas can arise from most any lymphatic tissue (lymph nodes, spleen, thymus, mucosa associated lymphoid...